Cederberg Capital’s NovaBridge Biosciences American Depositary Shares NBP Stock Holding History

Cederberg Capital’s Portfolio NBP Stock Details NBP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-2,215,385	Closed	-$9.26M	–	6
2022 Q4	$9.26M	Hold	2,215,385	–	–	3.08%	6
2022 Q3	$8.88M	Hold	2,215,385	–	–	3.46%	5
2022 Q2	$25M	Hold	2,215,385	–	–	6.63%	5
2022 Q1	$36M	Sell	2,215,385 -105,885	-5%	-$2.71M	9%	5
2021 Q4	$110M	Hold	2,321,270	–	–	21.78%	2
2021 Q3	$168M	Buy	2,321,270 +274,000	+13%	+$19.8M	21.87%	1
2021 Q2	$172M	Sell	2,047,270 -81,500	-4%	-$5.38M	15.46%	3
2021 Q1	$103M	Buy	2,128,770 +350,000	+20%	+$19M	7.59%	8
2020 Q4	$83.9M	Buy	+1,778,770	New	+$70M	3.08%	6

Other funds holding NBP

HHLR Advisors Grand Cayman, Cayman Islands $832M AUM 32.38% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Artal Group Luxembourg $931M AUM 41.63% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Cederberg Capital's NBP Position: Q1 2023 in Review

Cederberg Capital sold out of NovaBridge Biosciences American Depositary Shares (NBP) in Q1 2023, closing a stake of 2,215,385 shares — an estimated $9.26M sold.

Cederberg Capital first reported a position in NBP in Q4 2020 and held it in 9 quarters. The position peaked at $172M in Q2 2021. 53 funds tracked by Wall St. Rank hold NBP as of Q1 2023.

Cederberg Capital reported no remaining NovaBridge Biosciences American Depositary Shares position as of Q1 2023 after selling out during the quarter.
Cederberg Capital sold 2,215,385 NovaBridge Biosciences American Depositary Shares shares in Q1 2023, an estimated $9.26M.
Cederberg Capital first reported a position in NovaBridge Biosciences American Depositary Shares in Q4 2020 and held it in 9 quarters.
Cederberg Capital's NovaBridge Biosciences American Depositary Shares position peaked at $172M in Q2 2021.
53 funds tracked by Wall St. Rank held NovaBridge Biosciences American Depositary Shares as of Q1 2023.

Based on Cederberg Capital's 13F filing for Q1 2023, filed 15 May 2023.